In 2010, the Affordable Care Act defined a process intended to introduce competition to biologic drugs. For years, generic competition...
Year: 2021
Primary Care: A Symphony or a Cacophony?
Your simple act of walking into a primary care office sets off a series of events orchestrated by unseen conductors....
Pharma’s Fight Against 340B Contract Pharmacies
As written into law, the 340B program requires pharmaceutical companies to offer discount pricing on their drug products to many...
The Growth of Hospital Specialty Pharmacies Impacts Manufacturers
Specialty Pharmacies (SP) are big business. They currently fill prescriptions that represent nearly half of overall drug costs in the...